Fibrosis News and Research RSS Feed - Fibrosis News and Research

Fibrosis is the growth of fibrous tissue.
Researchers identify protein that degrades and inhibits infectious biofilms

Researchers identify protein that degrades and inhibits infectious biofilms

Many infectious pathogens are difficult to treat because they develop into biofilms, layers of metabolically active but slowly growing bacteria embedded in a protective layer of slime, which are inherently more resistant to antibiotics. [More]
Researchers crack genetic code of lung tissues to identify novel targets for treating IPF

Researchers crack genetic code of lung tissues to identify novel targets for treating IPF

Researchers cracked the complete genetic code of individual cells in healthy and diseased human lung tissues to find potential new molecular targets for diagnosing and treating the lethal lung disease Idiopathic Pulmonary Fibrosis (IPF). [More]
New drug treatment can override genetic fault that causes choroideremia

New drug treatment can override genetic fault that causes choroideremia

Researchers with funding from Fight for Sight have demonstrated that a new drug treatment for cystic fibrosis and Duchenne muscular dystrophy can override a genetic fault that causes choroideremia – a severe blinding disorder. [More]
Newcastle scientists develop promising new test to identify patients with rare liver disease

Newcastle scientists develop promising new test to identify patients with rare liver disease

Newcastle scientists and medics have developed a promising new test to identify patients with a rare liver disease who will not respond to standard treatment, allowing earlier intervention with alternatives. [More]
Elucigene collaborates with Congenica to develop new NGS kit for cystic fibrosis

Elucigene collaborates with Congenica to develop new NGS kit for cystic fibrosis

The emergence of new therapies that treat the causes of cystic fibrosis are creating an imperative for more accurate variant analysis. [More]
New UGA research finds pathogen's motility activates immune response

New UGA research finds pathogen's motility activates immune response

Until now, a pathogen's ability to move through the body has been overlooked as a possible trigger of immune response, but new research from the University of Georgia College of Veterinary Medicine found that motility will indeed alarm the host and activate an immune response. [More]
Cigarette smoking may lead to fibrosis in the heart and kidneys, study reveals

Cigarette smoking may lead to fibrosis in the heart and kidneys, study reveals

Smoking may lead to fibrosis in the heart and kidneys and can worsen existing kidney disease, according to a new study. [More]
New three-dimensional map of cystic fibrosis protein offers new insights to treating fatal disease

New three-dimensional map of cystic fibrosis protein offers new insights to treating fatal disease

Rockefeller scientists have created the first three-dimensional map of the protein responsible for cystic fibrosis, an inherited disease for which there is no cure. [More]
MILabs to provide Adaptive X-ray CT system to UAB for advancing pulmonary research

MILabs to provide Adaptive X-ray CT system to UAB for advancing pulmonary research

MILabs will provide an advanced U-CTUHR microCT system to the Cystic Fibrosis Research Center (CFRC) at the University of Alabama at Birmingham (UAB). [More]
UL researchers secure funding for new cystic fibrosis device

UL researchers secure funding for new cystic fibrosis device

A medical device for Cystic Fibrosis (CF) sufferers which lessens their exposure to infections resulting in fewer doctors’ visits, reduced antibiotic usage and shorter hospital stays, is expected to be market ready within two years. [More]
WSU researchers develop novel technology to treat chronic wound infections

WSU researchers develop novel technology to treat chronic wound infections

A WSU research team has successfully used a mild electric current to take on and beat drug-resistant bacterial infections, a technology that may eventually be used to treat chronic wound infections. [More]
New appointment to accelerate discovery of patient-centred medicines

New appointment to accelerate discovery of patient-centred medicines

The new Medicines Discovery Catapult (MDC) is pleased to announce the appointment of Ed Owen to put medical research charities and patient groups at the heart of the development of new therapies in the UK. [More]
ASGCT seeks to educate public and policy-makers on fundamentals of gene editing

ASGCT seeks to educate public and policy-makers on fundamentals of gene editing

On Nov. 21, 2016, the American Society of Gene & Cell Therapy released Therapeutic Gene Editing: an ASGCT White Paper, intended to provide policy-makers, patient advocates, and the interested public with the necessary background information in anticipation of an upcoming consensus report on human gene editing from the National Academy of Sciences and National Academy of Medicine (NAS), expected to be released in early 2017. [More]
NTM lung infections

NTM lung infections

Nontuberculous mycobacteria are part of a group of bacteria called mycobacteria. The non-tuberculous mycobacteria are, as the name suggests, mycobacteria that are not tuberculosis. They're also not leprosy, but they are the other members of the bacteria group termed mycobacteria. [More]
Palliative care improves patients' survival and quality of life, study shows

Palliative care improves patients' survival and quality of life, study shows

People living with serious illness who receive palliative care have better quality of life and fewer symptoms than those who don't receive palliative care, according to a new study by researchers at the University of Pittsburgh School of Medicine. [More]
Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen

Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen

The first thing that is important to stress is that this is an area that we actually know very little about. What we generally think, rather than know, is that NTM has a lot in common with pulmonary tuberculosis. [More]
Promethera presents new preclinical NASH-Fibrosis data from HepaStem program at AASLD meeting

Promethera presents new preclinical NASH-Fibrosis data from HepaStem program at AASLD meeting

Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem’s unique and multifaceted mode of action. [More]
BUSM researchers show how MRI can effectively identify bone marrow cancer in experimental model

BUSM researchers show how MRI can effectively identify bone marrow cancer in experimental model

For the first time, researchers have shown that using Magnetic Resonance Imaging (MRI) can effectively identify bone marrow cancer (myelofibrosis) in an experimental model. [More]
Particular eating behaviors linked to lower odds of developing liver diseases

Particular eating behaviors linked to lower odds of developing liver diseases

Particular eating behaviors may lower the risk of developing non-alcoholic fatty liver disease (NAFLD), according to research presented this week at The Liver Meeting — held by the American Association for the Study of Liver Diseases. [More]
New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

A new class of therapies may be on the horizon for thyroid eye disease (TED) and other destructive scarring conditions. [More]
Advertisement
Advertisement